Issue 8, 2021, Issue in Progress

Retraction: MiR-206 reduced the malignancy of hepatocellular carcinoma cells in vitro by inhibiting MET and CTNNB1 gene expressions

Abstract

Retraction of ‘MiR-206 reduced the malignancy of hepatocellular carcinoma cells in vitro by inhibiting MET and CTNNB1 gene expressions’ by Qiang He et al., RSC Adv., 2019, 9, 1717–1725, DOI: 10.1039/C8RA09229J

Associated articles

Article information

Article type
Retraction
Submitted
12 Jan 2021
Accepted
12 Jan 2021
First published
21 Jan 2021
This article is Open Access
Creative Commons BY license

RSC Adv., 2021,11, 4439-4439

Retraction: MiR-206 reduced the malignancy of hepatocellular carcinoma cells in vitro by inhibiting MET and CTNNB1 gene expressions

L. Fisher, RSC Adv., 2021, 11, 4439 DOI: 10.1039/D1RA90022F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements